ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,947, issued on Sept. 23, was assigned to Najit Technologies Inc. (Beaverton, Ore.).
"Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production" was invented by Ian J. Amanna (Hillsboro, Ore.) and Elizabeth A. Poore (Portland, Ore.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for rapidly inactivating a pathogen, or for producing a vaccine composition containing an inactivated noninfectious pathogen having retained antigenicity and/or immunogenicity, comprising exposing the pathogen to a chemical inactivating agent (e.g., one or more chemical oxidizing, alkylating...